Medical Device and Diagnostic Logistics: TCI EXPRESS at GPLS 2026

Medical device and diagnostic logistics cannot be planned as a standard movement for every product. A diagnostic reagent, laboratory instrument, replacement component and patient sample may each have different requirements for packaging, temperature, security, documentation, urgency and delivery.

This was a central point in the discussion at the 9th Global Pharma Logistics Summit, held in Mumbai on 9 October 2026. Industry leaders examined an important healthcare supply-chain question: can logistics help close the gap between testing, diagnosis and treatment?

Representing TCI EXPRESS, Chief Business Officer Mr Pabitra Mohan Panda explained why healthcare logistics needs a tailored approach:

“Just as you customise your medical devices, we customise our logistics solutions.”

The statement captures a practical reality. A logistics plan should begin with the product’s approved conditions and the customer’s actual requirement, not with a generic service promise.

What was discussed at the Global Pharma Logistics Summit 2026?

The Global Pharma Logistics Summit 2026 was organised by STAT MarCom at ITC Maratha in Mumbai. The event brought together pharmaceutical and biopharmaceutical companies, diagnostic organisations, medical-device manufacturers, healthcare institutions, logistics providers, packaging specialists, technology businesses and policymakers.

Mr Panda participated in a session titled “Can logistics close the gap between testing, diagnosis and treatment?” The official summit agenda framed the discussion around the movement of biological samples, diagnostic materials, reagents and healthcare products, and the need for traceability, chain-of-custody controls, suitable temperature management and coordinated transport.

The session connected several parts of healthcare that are often considered separately. A test may require a collection kit or reagent. A laboratory may need the sample and related information within defined conditions. A diagnostic system may depend on calibrated equipment, consumables or a critical replacement part. A treatment decision may then rely on the result being available to an authorised medical professional.

Logistics does not make the clinical decision, validate a test or determine a treatment. Its role is to support the approved movement plan so that accepted materials, devices and supplies reach the authorised location under the conditions defined by the responsible product owner, laboratory, healthcare institution or quality function.

Why does healthcare logistics need a customised approach?

The expression “healthcare cargo” covers products with very different characteristics. Even two items used in the same diagnostic process may require different packaging, storage or delivery arrangements.

A customised logistics assessment may need to consider:

• The exact product or material being moved
• Its regulatory and commercial classification
• Manufacturer-defined storage and transport conditions
• Permitted temperature range and excursion procedure
• Package dimensions, actual weight and value
• Fragility, orientation or shock sensitivity
• Sterility, contamination or biosecurity considerations
• Required documentation and chain of custody
• Pickup and receiving hours
• Required delivery window and escalation contacts

These inputs help determine whether the shipment can be accepted and which operating plan may be suitable. Customisation does not mean that every requested condition is automatically available. It means that the logistics provider evaluates the declared requirement before confirming the service, route, capacity and responsibilities.

What is the logistics gap between testing, diagnosis and treatment?

The gap is not one physical distance. It is the series of handovers, decisions and dependencies that connect the material needed for a test with the information needed for a clinical decision.

Depending on the healthcare process, logistics may involve moving:

• Diagnostic instruments and installation components
• Reagents, consumables and collection kits
• Medical devices and accessories
• Service parts needed to restore critical equipment
• Approved laboratory or research material
• Pharmaceutical products required after diagnosis

Not all these items belong in the same network or packaging system. Biological specimens and regulated materials may require specialised, authorised processes that are different from the movement of equipment or spare parts. Acceptance must be checked before booking, and no customer should assume that a general healthcare service includes every sample, device or regulated commodity.

A delay at any stage can affect the wider workflow. A reagent that misses the laboratory’s receiving window, a device held for incomplete documentation or an unavailable replacement component may interrupt the planned sequence. This is why healthcare logistics must connect product information, transport planning and receiving readiness.

How should medical-device logistics be planned?

Medical devices range from small consumables to sensitive diagnostic instruments and large capital equipment. The Central Drugs Standard Control Organisation states that medical devices in India are regulated under the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017.

The rules and associated guidance place responsibility on authorised parties across the device lifecycle. The logistics plan should therefore follow the conditions defined by the manufacturer, licence holder, importer, distributor or other responsible organisation. A transport provider should not independently invent a storage range or handling rule.

Before dispatch, the shipper should confirm:

• Complete device description and model information
• Serial, lot or batch references where applicable
• Final packed dimensions and actual gross weight
• Declared value and insurance arrangements
• Permitted stacking and orientation
• Shock, vibration, moisture or temperature limitations
• Accessory, cable and component checklist
• Calibration or installation dependencies
• Site access, unloading and receiving arrangements
• Applicable invoice, e-way bill and regulatory records

Large or sensitive equipment may also require a site-readiness review. The vehicle may reach the hospital or laboratory on time, but delivery can still be delayed if the gate, loading area, lift, doorway or authorised receiving team is unavailable.

How should diagnostic materials be assessed?

Diagnostic supply chains may include instruments, reagents, test kits, controls, consumables and, in specially authorised systems, biological material. Each category requires its own acceptance review.

The product owner or authorised quality team should define:

• Required storage and transport conditions
• Approved packaging configuration
• Temperature-monitoring requirement
• Maximum permitted journey or stability period
• Action to take after a delay or temperature excursion
• Required chain-of-custody evidence
• Authorised sender and receiver
• Applicable biosafety, biosecurity and regulatory controls

World Health Organization guidance notes that medical products can be exposed to risks during storage, transportation and distribution. Its good storage and distribution guidance emphasises controlled processes, suitable premises and equipment, documentation, traceability and risk management.

Biological samples require particular caution. Their classification, packaging, marking, documentation and transport must follow the applicable laws and authorised procedures. TCI EXPRESS service availability for any such material must be confirmed explicitly; a general article or service page is not proof of acceptance.

Why do temperature control and monitoring need separate decisions?

Not every healthcare shipment requires a cold chain. Some products may move under controlled ambient conditions, while others require refrigerated, frozen or another defined range. The authorised product documentation must establish the requirement.

Temperature control and temperature monitoring are related but different:

• Temperature control is the packaging, equipment and operating process used to maintain the required range.
• Temperature monitoring records or indicates what conditions occurred during the defined period.

A sensor does not control temperature by itself, and a temperature-controlled container does not remove the need for monitoring when the approved process requires it. The plan should define the monitoring device, placement, reading interval, data ownership, alarm process and authority to decide whether an excursion affects product disposition.

TCI EXPRESS provides a dedicated Cold Chain Express offering for evaluated temperature-sensitive requirements. The appropriate packaging, vehicle, monitoring and route must still be confirmed for the individual product and lane.

An operational perspective: Validated cold-chain assets, sensitive equipment handling and 24/7 Control Tower governance

For an express logistics provider like TCI EXPRESS, supporting healthcare, diagnostic and medical-device clients demands disciplined operating protocols designed around delicate, high-value assets and strict regulatory parameters:

• Engineered Handling for Sensitive Capital Equipment: High-precision diagnostic systems, analyzers, and imaging components require specialized physical handling. TCI EXPRESS deploys shock-absorbing containerized vehicles, secure mechanical lashing, and trained handling teams to prevent shock, vibration, or tilt during long-haul surface transit.
• Validated Cold Chain Express Networks: For temperature-dependent in vitro diagnostic (IVD) reagents, test kits, and biospecimens, Cold Chain Express maintains dedicated multi-temperature bands (2°C to 8°C and 15°C to 25°C). Reefers feature dual-sensor continuous logging and pre-cooled loading protocols to preserve product efficacy from dock to clinic.
• Expedited Domestic Air Express Corridors: When laboratory uptime is threatened by instrument failure or stock-outs of critical reagents, TCI EXPRESS utilizes prioritized commercial air allocations to deliver critical spares and diagnostic kits across major metros and tier-2 medical hubs within 24 to 48 hours.
• Strict Chain of Custody & 24/7 Control Tower: Consignments are tracked continuously via GPS telematics and barcode scanning across every physical touchpoint. Tamper-evident seals, automated milestone alerts, and instant digital Proof of Delivery (ePOD) provide healthcare compliance teams with transparent, verifiable audit trails conforming to CDSCO and WHO Good Distribution Practices.

By treating healthcare movements as critical patient-care links rather than generic freight, tailored logistics preserves cargo integrity across every milestone of the journey.

What does end-to-end visibility mean in healthcare logistics?

Visibility is useful when it helps an authorised person understand what has happened and decide what to do next. A map location alone may not explain whether the cargo was collected, accepted, transferred, delayed, exposed to an exception or delivered to the correct recipient.

Useful logistics milestones may include:

• Pickup request accepted
• Shipment collected
• Origin processing completed
• Line-haul or flight connection confirmed
• Destination processing completed
• Out for delivery
• Delivered to the authorised recipient
• Electronic proof of delivery available

Existing customers can follow available events through the TCI EXPRESS shipment tracking facility. Healthcare customers may also need additional reports, alerts or quality records under their approved account arrangement.

Visibility should connect with escalation. If an expected milestone does not occur, the team needs a defined contact, a timestamped record, an authorised decision and a closure process.

Why is chain of custody important?

Chain of custody records who had responsibility for a shipment or controlled item at each relevant handover. This can be important for high-value devices, sensitive diagnostic material, regulated products and healthcare consignments that require strict recipient authorisation.

A workable chain-of-custody process may record:

• Shipment or package identifier
• Sender and authorised receiver
• Date, time and location of each handover
• Condition or seal status when required
• Person or system recording the event
• Exceptions and authorised instructions
• Final delivery evidence

The exact record depends on the product, regulation, customer quality agreement and service. A normal delivery scan should not be described as a complete regulated chain-of-custody record unless the agreed process actually supports that requirement.

When can urgent transport support healthcare operations?

Urgency may arise when a diagnostic instrument stops working, a replacement component is needed, a laboratory faces a reagent shortage or an accepted healthcare product must reach a destination within a defined period.

Faster movement should not bypass acceptance, packaging or documentation requirements. Before approving an urgent plan, the customer and logistics provider should confirm:

• What business or healthcare process is affected
• The latest useful delivery time
• Whether the commodity is accepted on the proposed mode
• Whether packaging remains suitable for the full journey
• Which connection and final-delivery plan are available
• Who can approve a changed route or additional cost
• Who will receive the goods at destination

Time-sensitive accepted cargo may be assessed through Domestic Air Express. The actual route, flight capacity, commodity acceptance, cutoff and final delivery must be confirmed. Larger direct movements may instead require an assessment through C2C Express or another suitable service.

How TCI EXPRESS approaches healthcare logistics

TCI EXPRESS describes its pharmaceutical and healthcare logistics capabilities as part of a wider express-service network. The service discussion can include product characteristics, origin and destination, temperature requirement, package profile, urgency, documentation and visibility needs.

Mr Panda’s summit observation explains the guiding approach: the logistics solution should be built around the declared product and use case. This is particularly relevant in healthcare because one standard process cannot safely describe every medicine, device, reagent, instrument or sample.

A customer considering a healthcare movement should begin with an initial serviceability check through the TCI EXPRESS pin-code enquiry, then provide the complete shipment requirement through the business enquiry channel or its approved account contact. Final acceptance depends on the commodity, lane, packaging, documentation, capacity and agreed service conditions.

From summit discussion to practical supply-chain action

TCI EXPRESS’s participation at GPLS 2026 followed its earlier pre-event Global Pharma Logistics Summit announcement. The post-event discussion adds a more specific lesson: healthcare logistics must be designed around what is moving and why it matters.

Closing the distance between testing, diagnosis and treatment requires more than speed. It requires correct product information, an accepted transport plan, controlled handling, useful visibility, authorised handovers and a receiving team ready to act.

Logistics cannot replace the medical, laboratory or quality decisions made by healthcare professionals. It can, however, help connect the approved materials, devices and supplies required for those decisions. That connection is strongest when every participant understands the product, the responsibility and the next step.